We confirmed the enhanced production of IFN‐β at both protein and mRNA levels in various cancer cell lines, including colorectal (MC38 and CT26), melanoma (B16), pancreatic (Panc02 and CT1BA5) and breast (4T1) cancer cells. This evidence concerns the gene IFNB1 and melanoma.